Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.

about

Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.

Item

http://www.wikidata.org/entity/Q38655720

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Routine use of clinical exome- ...... thrombotic microangiopathies.

@en

type

Item

label

Routine use of clinical exome- ...... thrombotic microangiopathies.

@en

prefLabel

Routine use of clinical exome- ...... thrombotic microangiopathies.

@en

P1476

Routine use of clinical exome- ...... thrombotic microangiopathies.

@en

P2093

Catherine E Cottrell

http://www.w3.org/2001/XMLSchema#string

John D Pfeifer

http://www.w3.org/2001/XMLSchema#string

Jonathan W Heusel

http://www.w3.org/2001/XMLSchema#string

Joseph P Gaut

http://www.w3.org/2001/XMLSchema#string

Katinka A Vigh-Conrad

http://www.w3.org/2001/XMLSchema#string

Meagan Corliss

http://www.w3.org/2001/XMLSchema#string

Mukesh K Sharma

http://www.w3.org/2001/XMLSchema#string

Sanjay Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Analysis of protein-coding genetic variation in 60,706 humans

The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities

The Sequence Alignment/Map format and SAMtools

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

P2888

modpathol.2017.90

P304

1739-1747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2017.90

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090915134

http://www.w3.org/2001/XMLSchema#string

P698

28752844

http://www.w3.org/2001/XMLSchema#string

P932

5716882

http://www.w3.org/2001/XMLSchema#string